FDA panel votes 8-5 that breo ellipta helps reduce lung disease severity (THRX) (GSK)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. AVGO
7. OSIS
8. BJ
9. NTES
10. DE

Go back to FDA panel votes 8-5 that breo ellipta helps reduce lung disease severity (THRX) (GSK)
GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 52.13 +0.17 (0.33%)
Previous Close $51.96    52 Week High $45.58 
Open $51.35    52 Week Low $37.82 
Day High $52.39    P/E N/A 
Day Low $51.35    EPS $0.00 
Volume 698,039       

Theravance, Inc. (NASDAQ: THRX) Delayed: 4.06 --0 (-0%)
Previous Close $4.06    52 Week High $21.16 
Open $0.72    52 Week Low $6.36 
Day High $4.06    P/E N/A 
Day Low $4.06    EPS $-1.53 
Volume 107,542